[Amantadine therapy in Parkinsonism].
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects; D010919:Placebos
D010276:Parasympatholytics; D010919:Placebos; D000547:Amantadine
Amantadin-behandling av parkinsonism.